CVI Holdings’s Eyegate Pharmaceuticals, Inc. Warrants EYEGW Stock Holding History

CVI Holdings’s Portfolio EYEGW Stock Details EYEGW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,900	Closed	–	–	56
2018 Q3	$0	Hold	12,900	–	–	﹤0.01%	62
2018 Q2	$1K	Hold	12,900	–	–	﹤0.01%	52
2018 Q1	$1K	Buy	+12,900	New	+$1.57K	﹤0.01%	45

Other funds holding EYEGW

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CVI Holdings's EYEGW Position: Q4 2018 in Review

CVI Holdings sold out of Eyegate Pharmaceuticals, Inc. Warrants (EYEGW) in Q4 2018, closing a stake of 12,900 shares.

CVI Holdings first reported a position in EYEGW in Q1 2018 and held it in 3 quarters. The position peaked at $1K in Q2 2018. 2 funds tracked by Wall St. Rank hold EYEGW as of Q4 2018.

CVI Holdings reported no remaining Eyegate Pharmaceuticals, Inc. Warrants position as of Q4 2018 after selling out during the quarter.
CVI Holdings sold 12,900 Eyegate Pharmaceuticals, Inc. Warrants shares in Q4 2018.
CVI Holdings first reported a position in Eyegate Pharmaceuticals, Inc. Warrants in Q1 2018 and held it in 3 quarters.
CVI Holdings's Eyegate Pharmaceuticals, Inc. Warrants position peaked at $1K in Q2 2018.
2 funds tracked by Wall St. Rank held Eyegate Pharmaceuticals, Inc. Warrants as of Q4 2018.

Based on CVI Holdings's 13F filing for Q4 2018, filed 14 Feb 2019.